Research compound

Tirzepatid

Tirzepatide is a peptide-based compound that activates GIP and GLP-1 receptors.

Specification
30 mg
Price
100,00 €

Research information

What is it?

Tirzepatide is a peptide-based compound that activates GIP and GLP-1 receptors.

Research information

Research focus

Clinical research has examined its effects on satiety, food intake, blood-glucose regulation and body-weight reduction.

PEPTIDE EUROPE / COA

Certificate of analysis

Documentation for the stated sample and batch.

Laboratory
Janoshik
Test date
1/19/2026
Report number
99786
Measured quantity
34.18 mg
Purity
99.783%

Edited copy: names and QR codes removed; sample photos omitted where supplied. Test data unchanged.

Verify with laboratory Verification key: ZFHPDJGANUI8

A laboratory report applies to its stated sample and tests. It does not establish clinical safety or efficacy.

Certificate of analysis · Janoshik · 99786View full document ↗

Research information only. Not medical advice.